AllInBio is a startup.
AllInBio is developing a precision immunology approach to identify genetically predisposed "at-risk" patient populations for chronic inflammatory diseases and enable their selection and early treatment to prevent rapid progression to severe disease.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.